Silent ischemia predicts poor outcome in high-risk healthy men∗∗Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.  by Deedwania, Prakash C
EDITORIAL COMMENT
Silent Ischemia Predicts
Poor Outcome in
High-Risk Healthy Men*
Prakash C. Deedwania, MD, FACC
San Francisco, California
Myocardial ischemia is well established as a reliable predic-
tor of physiologically significant coronary artery disease
(CAD) (1,2). During the past two decades, a large number
of epidemiologic studies and prospective observational data
have demonstrated that the presence of myocardial ischemia
is associated with adverse outcomes in asymptomatic indi-
viduals as well as those with established CAD (3–22). The
results of these reports emphasizing the prognostic signifi-
cance of myocardial ischemia in asymptomatic individuals
have led the American Heart Association and the American
College of Sports Medicine to recommend that apparently
healthy men ages $45 years and women .55 years (even
those without known cardiovascular risk factors) should
undergo a maximal exercise treadmill test before engaging in
a vigorous exercise program (23).
However, the issue of routine screening of apparently
healthy individuals for myocardial ischemia continues to be
a controversial issue and a topic of constant debate. This
issue is further compounded by the fact that, frequently,
myocardial ischemia detected by ST-segment depression
during stress testing in healthy individuals is not associated
with chest pain. Because of the absence of symptoms, it has
been suggested that the ST-segment changes without asso-
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ciated chest pain during stress testing in asymptomatic
subjects do not necessarily reflect ischemic changes and
could be a false-positive finding. Such confusion and ques-
tions have arisen largely because stress testing has been
occasionally used inappropriately in individuals with a low
pretest likelihood of CAD. However, when used in evalu-
ating appropriate individuals (those at high risk of develop-
ing CAD), exercise-induced ST-segment depression can
identify the subgroup with increased risk of future coronary
events and cardiac death.
The study by Laukkanen et al. (24) in this issue of the
Journal emphasizes this point by showing that exercise-
induced silent ischemia (SI), which was predominantly
silent, was associated with adverse outcome largely in the
apparently healthy individuals who were at high risk of
developing CAD owing to the presence of one of the three
conventional coronary risk factors (24). These findings
reported by Laukkanen et al. (24) raise several important
questions: 1) Should all healthy middle-aged individuals
with coronary risk factors undergo exercise testing to iden-
tify the future risk of cardiac events? If so, which ones are
likely to benefit the most from such testing? 2) Can these
results be generalized to individuals with other emerging
and newer coronary risk factors? 3) Perhaps the most
difficult and clinically relevant question would be: What
should be done in those with an abnormal test? Should the
individuals with exercise-induced ischemia be subjected to
further testing, including coronary angiography? And if
further testing is to be performed, how would it alter the
management of such asymptomatic individuals? These are
all clinically relevant and important questions that must be
addressed.
THE PRESENT STUDY
The report by Laukkanen et al. (24) describes the impor-
tance of exercise-induced silent myocardial ischemia in a
large cohort of middle-aged Finnish men with no prior
coronary heart disease (CHD) who participated in the
Kupio Ischemia Heart Disease Risk Factor Study. Of the
1,769 men who had complete interpretable electrocardio-
graphic (ECG) data obtained during a maximal symptom-
limited exercise test on the bicycle ergometer, 189 (10.7%)
had SI during exercise and 54 (3.1%) had ischemia during
the postexercise recovery period. The comparison of base-
line characteristics demonstrated that subjects with SI had
higher serum cholesterol, higher systolic blood pressure,
higher maximal heart rate and lower maximal oxygen uptake
(24).
The main results of the study (24) demonstrated that SI
during exercise predicted higher risk of acute coronary
events and CHD death predominantly in those subjects
with one of the three major coronary risk factors, which
include smoking, hypercholesterolemia and hypertension.
Although several previous studies have demonstrated similar
prognostic data in association with exercise-induced myo-
cardial ischemia, the Laukkanen et al. (24) study has several
unique features that deserve attention. First, it is important
to note that, unlike the previous reports on this subject,
patients who developed chest pain during the baseline
exercise test were excluded from the present study, making
this perhaps the first and best-published report regarding
the prognostic importance of SI during exercise testing in
apparently healthy individuals. Although the absolute risk
of coronary events and cardiac death during the follow-up
was low in the present study, it is important to note that
even after adjustment for conventional risk factors, men
with SI during exercise had significantly increased relative
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risk of acute coronary events and CHD death (24). Another
interesting finding in the study was the fact that even SI
detected during the postexercise recovery phase was associ-
ated with adverse clinical outcome, emphasizing the impor-
tance of close ECG monitoring in the recovery phase.
Despite all the interesting findings reported by Lauk-
kanen et al. in the present study (24), several critical
questions remain. First, the investigators have not provided
any information regarding the importance of multiple risk
factors in the individual with SI. It is generally well accepted
that the presence of two or more major risk factors, such as
hypertension, hypercholesterolemia, diabetes and smoking,
carries not just an additive but a multiplicative risk of future
cardiac events. Because many individuals in clinical practice
present with multiple risk factors, it would have been
interesting to learn from the present study if patients with
multiple risk factors had a higher incidence of SI and
subsequent cardiac events. Although the investigators have
only emphasized the interaction of SI with smoking, hyper-
cholesterolemia and hypertension in their study, the ques-
tion remains about the prognostic significance of SI in
individuals with low high-density lipoprotein (HDL) cho-
lesterol, which is reported as a strong predictor of acute
coronary events in the present study. This is particularly
important because isolated low HDL cholesterol is present
in a significant proportion of men with CHD, and the
overall prevalence of this risk factor is rising with the
increasing incidence of type II diabetes in the world.
It is also interesting to note that, in the present study,
high body-mass index (BMI) was also a strong predictor of
CHD death, raising the possibility that many of these men
with high BMI might have had dysmetabolic profile and
insulin-resistant state, shown to be associated with increased
cardiovascular risk (25). Although it is understood that the
present study was begun in 1984 and, as such, it could not
have incorporated the evaluation of the newer emerging risk
factors such as the inflammatory markers like C-reactive
protein (CRP), the question remains whether the presence
of SI would have similar or different association with CRP
for future risk of cardiac events. Finally, it is important to
note that the data presented in this study are largely limited
to middle-aged men and might not necessarily be applicable
to other subjects such as the elderly and women. Despite
these limitations, the present study by Laukkanen et al. (24)
does provide strong evidence in support of SI as an
important marker of adverse outcome in apparently healthy
middle-aged men with one or more conventional risk
factors.
PREVIOUS STUDIES
Several previous studies have evaluated the prognostic sig-
nificance of myocardial ischemia during exercise testing in
asymptomatic individuals (4–19). Most of these studies
have consistently demonstrated that myocardial ischemia
diagnosed by exercise-induced ST-segment depression is
associated with subsequent poor outcome (4–19). The
Seattle Heart Watch study was probably one of the earliest
and best investigations in this field (4,5). In this prospective
community study of .4,000 healthy subjects initiated in
1971, Bruce et al. (4,5) showed that the annualized risk of
cardiac death increased fivefold in individuals with any
conventional risk factors and the presence of $2 exercise
test predictors that included $1-mm ST-segment depres-
sion, chest pain during exercise, limited exercise capacity
and maximum achieved heart rate #90% of predicted.
In another study by McHenry et al. (8) of 916 apparently
healthy middle-aged (27 to 35 years) men, abnormal exer-
cise test findings were associated with a nearly eightfold
increase in the risk of cardiac events. The interaction of
conventional risk factors with exercise test findings was also
studied in the Multiple Risk Factor Interventional Trial
(MRFIT), the Lipid Research Clinic (LRC) mortality
follow-up study and the LRC Coronary Primary Prevention
Trial (LRC–CPPT) (10–12). In the MRFIT study, 12,422
healthy middle-aged men participated in exercise treadmill
test evaluation (10). During the seven-year follow-up, an
almost fourfold increase occurred in CHD mortality (10).
Similar data have been reported from the two LRC studies
(11,12). In the LRC mortality follow-up study, the abnor-
mal exercise test response was associated with a nearly
10-fold increase in the risk of cumulative mortality in men
with increased cholesterol during the 8-year follow-up (11).
In the LRC–CPPT, there was nearly a fivefold increase in
mortality in those with an ischemic response during the
treadmill exercise test (12).
In an attempt to evaluate the independent prognostic
value of ST-segment changes, Giagnoni et al. (9) performed
bicycle exercise tests in 10,723 subjects free of heart disease
and hypertension. Of these, 135 subjects had $1-mm
ST-segment depression. During the 6-year median
follow-up period, when compared to controls, the individ-
uals with ischemic ST-segment changes during exercise had
a fivefold greater risk of coronary events. In a recent study,
Katzel et al. (19) had specifically evaluated the role of
exercise-induced SI in 170 healthy, sedentary middle-aged
and older men. Of these, 37 men (22%) had exercise-
induced SI during treadmill testing. During the 7-year
follow-up, 17 of 37 men (46%) with SI had a significant
cardiac event compared to only 14 of 133 men (11%)
without SI (19).
Although these previous studies had shown that abnor-
mal exercise test findings in apparently healthy subjects were
associated with adverse outcome, it was not established
whether the poor outcome was directly associated with the
presence of myocardial ischemia or other abnormalities such
as poor functional capacity (4–16). Furthermore, these
studies did not specifically evaluate the role of SI because,
unlike the present study by Laukkanen et al. (24) patients
with chest pain were included. Also, none of these studies
provided information regarding the significance of ST
changes during the recovery phase. Additionally, the cardiac
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events often included soft end points such as the develop-
ment of anginal symptoms during the follow-up period.
Based on the results of these previous studies, as well as the
present study by Laukkanen et al. (24), it is quite evident
that exercise-induced myocardial ischemia in healthy sub-
jects is associated with subsequent adverse outcome.
SILENT OR SYMPTOMATIC ISCHEMIA:
DOES IT REALLY MATTER?
Although in the past considerable emphasis was placed on
anginal symptoms, the data from a number of studies have
now shown that the absence of pain should not be consid-
ered as a sign of insignificant disease or benign prognosis
(20–22). Several studies have evaluated the relative prog-
nostic value of silent versus painful ischemia (20–22,26).
Results of these studies have shown that the presence or
absence of anginal pain during exercise testing does not alter
the subsequent risk of death that is primarily related to the
presence of myocardial ischemia (21,22,26). In a recent
study, the functional significance of silent versus symptom-
atic ischemia during exercise testing was examined by
comparing the perfusion abnormalities on thallium-201
single-photon emission computed tomography (27). The
findings of the study revealed that, in the population with a
high likelihood of CAD, chest pain tends to lose its
apparent value as a clinical test parameter, and there was
little difference in the magnitude of perfusion abnormalities
between those with silent and symptomatic ischemia (27).
Previous studies in victims of sudden cardiac death and
survivors of cardiac arrest have also shown that there is no
significant difference in the extent of CAD in those with a
prior history of angina versus those with no symptoms
(28,29). Based on these data, it is becoming increasingly
apparent that it is the presence of myocardial ischemia
(regardless of the associated symptoms) that determines the
subsequent prognosis (20).
MECHANISMS RESPONSIBLE FOR ADVERSE IMPACT
OF SI IN ASYMPTOMATIC SUBJECTS
The precise mechanism by which SI leads to adverse
outcomes in otherwise healthy subjects is not known. There
are several potential explanations. Clearly, it is well accepted
that the presence of ischemia during exercise testing iden-
tifies individuals with significant CAD. Although ischemia
is generally produced by a flow-limiting stenotic lesion, the
process of atherosclerosis is generalized; therefore, it is quite
conceivable there are multiple atherosclerotic plaques in
various stages of progression. Indeed, some of these plaques
might have a large lipid core with an abundance of inflam-
matory cells, which makes the plaques susceptible to rupture
and thrombosis, thereby increasing the risk of acute coro-
nary events. The other possibility is that SI can lead to
life-threatening ventricular arrhythmias, especially in indi-
viduals who may have arrhythmic substrate such as hyper-
tensive patients with left ventricular hypertrophy or those
with left ventricular dysfunction.
Finally, repeated episodes of SI can have important
pathophysiologic consequences such as depletion of energy
stores, cell death, subendocardial necrosis and areas of
patchy myocardial fibrosis (30,31). Over time these pro-
cesses can lead to progressive left ventricular dysfunction.
Future studies should evaluate the specific pathophysiologic
consequences of SI in humans to understand better the
mechanism(s) responsible for adverse prognosis.
CLINICAL IMPLICATIONS AND FUTURE DIRECTION
The findings described in the study by Laukkanen et al. (24)
raise several important clinical questions such as who should
be tested, what should be done for those with abnormal
findings and ways to improve the clinical outcome in the
high-risk subset. Clearly, it is neither feasible nor advisable
to screen every middle-aged man for myocardial ischemia.
As previously emphasized and based on the results of the
present study, it would seem prudent to recommend the
screening exercise stress test only for high-risk healthy
subjects such as those with $2 coronary risk factors. Such a
strategy would not only avoid unnecessary testing in low-
risk individuals but also reduce the risk of false-positive
findings. The next question is obviously what to do for those
with evidence of SI detected during exercise testing. It is
generally recommended that the presence of myocardial
ischemia detected by ECG changes during exercise testing
should be confirmed by an imaging study, such as myocar-
dial perfusion scintigraphy or a stress echocardiography
study, depending on the local expertise. Previous reports
have shown that such an imaging study is not only helpful
in confirming the presence of myocardial ischemia and
diagnosis of CAD but also provides additional prognostic
information. In general, coronary angiography should be
reserved for those with findings suggestive of high-risk
CAD on the imaging study. A good deal of caution and
restraint is, however, required to avoid unnecessary proce-
dures that might not only be expensive and inappropriate
but also have the potential for harm.
The final obvious question concerns what can be done to
alter the adverse prognosis associated with SI in apparently
healthy subjects. The most important action in this regard
would be directed toward aggressive risk-factor modifica-
tion, including smoking cessation measures, control of
blood pressure in hypertensive subjects and lipid-lowering
therapy in those with hypercholesterolemia. Although, in
general, the benefits of such risk factor modification strat-
egies are well established, little information is available
regarding the specific effects of such therapies in high-risk
healthy subjects with SI. Future studies should evaluate the
impact of various therapeutic strategies on the clinical
outcome in asymptomatic patients with SI.
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